Skip to content

Orthopaedic Products
Innovation & Development
Company Information
News & Updates
Get in Touch!

Orthopaedic
Products
- UPPER
  LIMB
  - Clavicle
    - Shoulder
      - Hand & Wrist
- LOWER
  LIMB
  - Hip
    - Knees
      - Foot & Ankle
        
        CustomLINK
- BLADES, WIRES
  & INSTRUMENTS
  - Blades
    - Wires & Pins
      - Instruments
Innovation
& Development
- CURRENT PROJECTS
  - Sr-HT-Gahnite
- PARTNER WITH US
Company
Information
- ABOUT ALLEGRA
  - About Us
  - Senior Management
- INVESTORS
News
& Updates
Get in
Touch!

Home » 17/03/15: Cancellation of Shares

News & Updates

17/03/15: Cancellation of Shares

17 March 20153 May 2018 •

Related

Allegra confirms route to FDA approval following successful pilot animal study

Reconstruction for Acetabular Metastatic Disease

Meet Dr Nick Hartnell, Surgeon Advisor

Recent Posts

Company Update – Innovation Division Shareholder Presentation August 2023
Meet Dr Roger Brighton, Surgeon Advisor
Improving Coating Techniques for Orthopaedic Implants
Exclusive Distribution of ChiroKlip®
Allegra confirms route to FDA approval following successful pilot animal study

Categories

Company News
Innovation & Development
Products

Keep up to date!

Receive newsletter updates weekly.

Privacy Policy | Sitemap
Corporate Governance
© Allegra

Customer Service

Phone: 1800 644 370
Fax: 1800 624 223
Email: sales@allegraorthopaedics.com

Corporate Office

Level 8, 18-20 Orion Road,
Lane Cove West, NSW 2066
Phone: +61 2 9119 9200
Fax: +61 2 9439 4441